Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
JAMA Network Open
|
November 30, 2021
Evaluating the Value of a New Prediction Model for Gastric Cancer
Jesse A Berlin, Daniel V Catenacci
Future Oncology (London, England)
|
November 3, 2017
Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma
Smita S Joshi, Steven B Maron, Daniel V Catenacci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2017
It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma
Elena Elimova, Yelena Y Janjigian, Mary Mulcahy, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
Daniel Lin, Uqba Khan, Thorsten O Goetze, et al.
Surgery
|
October 10, 2018
Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial
Fadi S Dahdaleh, Scott K Sherman, Elizabeth C Poli, et al.
Pancreas
|
September 22, 2015
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma
Andrew H Ko, Noelle LoConte, Margaret A Tempero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2020
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
Manish A Shah, Erin B Kennedy, Daniel V Catenacci, et al.
The Oncologist
|
July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Daniel V Catenacci, Joseph Chao, Kei Muro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors
Gerald S Falchook, Razelle Kurzrock, Hesham M Amin, et al.
The Oncologist
|
May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy
Aparna R Parikh, Yuting He, Ted S Hong, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
JAMA Network Open
|
November 30, 2021
Evaluating the Value of a New Prediction Model for Gastric Cancer
Jesse A Berlin, Daniel V Catenacci
Future Oncology (London, England)
|
November 3, 2017
Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma
Smita S Joshi, Steven B Maron, Daniel V Catenacci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2017
It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma
Elena Elimova, Yelena Y Janjigian, Mary Mulcahy, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
Daniel Lin, Uqba Khan, Thorsten O Goetze, et al.
Surgery
|
October 10, 2018
Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial
Fadi S Dahdaleh, Scott K Sherman, Elizabeth C Poli, et al.
Pancreas
|
September 22, 2015
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma
Andrew H Ko, Noelle LoConte, Margaret A Tempero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2020
Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline
Manish A Shah, Erin B Kennedy, Daniel V Catenacci, et al.
The Oncologist
|
July 21, 2021
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Daniel V Catenacci, Joseph Chao, Kei Muro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors
Gerald S Falchook, Razelle Kurzrock, Hesham M Amin, et al.
The Oncologist
|
May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy
Aparna R Parikh, Yuting He, Ted S Hong, et al.
Page
of 2